Clinical Trials in Rockville Centre, New York
81 recruiting
Showing 1–20 of 81 trials
Recruiting
Phase 2
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Non-small Cell Lung CancerNSCLCNon-small Cell Lung Cancer Metastatic+2 more
Memorial Sloan Kettering Cancer Center68 enrolled9 locationsNCT05657873
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
Stryker Instruments8,000 enrolled2262 locationsNCT03072927
Recruiting
Not Applicable
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Deep Venous ThrombosisVenous Thromboembolism
Memorial Sloan Kettering Cancer Center259 enrolled8 locationsNCT07399977
Recruiting
Phase 2
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Solid TumorWilms TumorRhabdoid Tumor+4 more
Memorial Sloan Kettering Cancer Center45 enrolled16 locationsNCT05985161
Recruiting
Phase 2
A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest
Thymic MalignanciesPleural Metastases
Memorial Sloan Kettering Cancer Center36 enrolled7 locationsNCT05354570
Recruiting
Not Applicable
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
SurgeryHead and Neck Disorder
Memorial Sloan Kettering Cancer Center27 enrolled7 locationsNCT06676592
Recruiting
Phase 2
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Acute Lymphoblastic LeukemiaHodgkin LymphomaNon-Hodgkin Lymphoma+5 more
Memorial Sloan Kettering Cancer Center71 enrolled7 locationsNCT07566377
Recruiting
Phase 2
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
High-grade B-cell LymphomaDiffuse Large B-Cell Lymphoma (DLBCL)
Memorial Sloan Kettering Cancer Center42 enrolled7 locationsNCT06765317
Recruiting
Phase 3
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Neovascular Age-related Macular Degeneration
Hoffmann-La Roche1,000 enrolled165 locationsNCT03683251
Recruiting
Not Applicable
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Non-Hodgkin LymphomaMultiple Myeloma
Memorial Sloan Kettering Cancer Center20 enrolled8 locationsNCT07249528
Recruiting
Phase 1
A Study of CRD3874-SI in People With Solid Tumors
SarcomaMerkel Cell Carcinoma
Memorial Sloan Kettering Cancer Center81 enrolled7 locationsNCT06021626
Recruiting
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Cancer Patients
Memorial Sloan Kettering Cancer Center347 enrolled11 locationsNCT01742143
Recruiting
Phase 1Phase 2
A Study of Mirdametinib in People With Central Nervous System Tumors
GliomaCentral Nervous System Tumors
Memorial Sloan Kettering Cancer Center26 enrolled7 locationsNCT07539441
Recruiting
Phase 3
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
NRG Oncology1,670 enrolled832 locationsNCT04852887
Recruiting
Factors Associated With Breast Cancer Risks and Outcomes
Breast Cancer
Memorial Sloan Kettering Cancer Center750 enrolled7 locationsNCT07294703
Recruiting
Phase 2
A Study of Isoquercetin in People With Ovarian Cancer
Ovarian CancerEpithelial Ovarian CancerSerous Ovarian Tumor
Memorial Sloan Kettering Cancer Center90 enrolled8 locationsNCT07303894
Recruiting
Phase 2
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
Gastrointestinal Cancer
Memorial Sloan Kettering Cancer Center216 enrolled8 locationsNCT05789485
Recruiting
Phase 2
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
Prostate Cancer
Memorial Sloan Kettering Cancer Center57 enrolled7 locationsNCT06347705
Recruiting
Phase 2
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
CancerPeriod Problem
Memorial Sloan Kettering Cancer Center60 enrolled7 locationsNCT06915116
Recruiting
Phase 2
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Hematologic MalignancyGraft vs Host DiseaseGraft-Versus-Host Disease
Memorial Sloan Kettering Cancer Center46 enrolled8 locationsNCT07006506